120
Participants
Start Date
April 14, 2016
Primary Completion Date
September 4, 2019
Study Completion Date
July 23, 2021
Azacitidine
Azacitidine intravenous or subcutaneous formulation.
Pevonedistat
Pevonedistat intravenous infusion.
Tallaght Hospital, Dublin
University Multiprofile Hospital for Active Treatment Sv Ivan Rilski EAD, Sofia
Specialized Hospital for Active Treatment of Haematological Diseases - Sofia, Sofia
University Multi-Profile Hospital for Active Treatment Dr Georgi Stranski, Sofia
Cliniques Universitaires UCL de Mont-Godinne, Yvoir
Grand Hopital de Charleroi asbl, Charleroi
Hospital Universitario Son Espases, Palma de Mallorca
Hospital Clinic de Barcelona, Barcelona
AZ Sint-Jan AV, Bruges
Hospital Universitario Germans Trias i Pujol, Badalona
Weill Cornell Medical College, New York
Columbia University Medical Center, New York
Fakultni Nemocnice Kralovske Vinohrady, Prague
Azienda Ospedaliero Universitaria San Giovanni Battista Di Torino, Torino
Monter Cancer Center, Lake Success
ZIV Medical Center, Safed
Tel Aviv Sourasky Medical Center, Tel Aviv
University of Rochester Medical Center, Rochester
Johns Hopkins University, Baltimore
University of Virginia, Charlottesville
University of North Carolina at Chapel Hill, Chapel Hill
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón
Hospital Regional Universitario de Malaga - Hospital Universitario Virgen de la Victoria, Málaga
University of Miami Miller School of Medicine, Miami
H Lee Moffitt Cancer Center and Research Institute, Tampa
University of Alabama, Birmingham
Hospital Universitario de Salamanca, Salamanca
CHU de GRENOBLE, Grenoble
Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi, Bologna
Marien Hospital Akademisches Lehrkrankenhaus, Düsseldorf
Cleveland Clinic, Cleveland
Hospital Clinico Universitario de Valencia, Valencia
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
Azienda Ospedaliera Universitaria Careggi, Florence
CHRU Lille, Lille
University of Chicago Medical Center, Chicago
Greenville Health System, Little Rock
Hopital Saint Louis, Paris
Texas Oncology - Waco, TX, Tyler
Nebraska Cancer Specialists, The Woodlands
Cancer Care Center of South Texas, New Braunfels
Rocky Mountain Cancer Centers, Aurora
San Juan Oncology Associates, Farmington
Universitatsklinikum Ulm, Ulm
Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria
UC San Diego Moores Cancer Center, La Jolla
Compassionate Cancer Care Medical Group Incorporated, Riverside
Yakima Valley Memorial Hospital, Yakima
Medical Oncology Associates, Spokane
Shaare Zedek Medical Center, Jerusalem
Smilow Cancer Center at Yale New Haven Hospital, New Haven
Sunnybrook Health Science Centre, Toronto
Princess Margaret Hospital, Toronto
Fakultni Nemocnice Brno, Brno
University Hospital Galway, Galway
Zuyderland Medisch Centrum, Sittard
ICO I'Hospitalet Hospital Duran i Reynals Instituto Catalan de Oncologia de Hospitalet (ICO), Barcelona
Lead Sponsor
Millennium Pharmaceuticals, Inc.
INDUSTRY